Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 06:46 am Sale |
2024-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 4,342,500 2.760% |
-1,727,500 (-28.46%) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Venrock Healthcare Capital Partners III L.P. | 13,760,200 8.700% |
5,984,440 (+76.96%) |
Filing History |
| 2024-11-14 09:37 am Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
AVORO CAPITAL ADVISORS LLC | 12,714,874 7.900% |
12,714,874 (New Position) |
Filing History |
| 2024-11-12 4:49 pm Unchanged |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
The Vanguard Group | 8,384,183 5.370% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
BLACKROCK INC BLK |
11,354,164 7.300% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:42 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
The Vanguard Group | 8,384,183 5.370% |
3,266,081 (+63.81%) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
BLACKROCK INC BLK |
11,354,164 7.300% |
5,592,631 (+97.07%) |
Filing History |
| 2024-02-27 4:30 pm Purchase |
2024-02-26 | 13D | Ocular Therapeutix, Inc. OCUL |
Summer Road LLC | 14,360,633 9.400% |
930,851 (+6.93%) |
Filing History |
| 2024-02-14 7:48 pm Sale |
2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 6,070,000 5.510% |
-5,000 (-0.08%) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Ocular Therapeutix, Inc. OCUL |
The Vanguard Group | 5,118,102 4.460% |
1,141,249 (+28.70%) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BLACKROCK INC BLK |
5,761,533 5.200% |
808,796 (+16.33%) |
Filing History |
| 2023-12-28 4:17 pm Purchase |
2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL |
Venrock Healthcare Capital Partners III L.P. | 7,775,760 6.800% |
7,775,760 (New Position) |
Filing History |
| 2023-12-22 4:04 pm Purchase |
2023-12-14 | 13G | Ocular Therapeutix, Inc. OCUL |
Deep Track Capital, LP | 9,230,769 8.380% |
9,230,769 (New Position) |
Filing History |
| 2023-12-18 4:52 pm Purchase |
2023-12-14 | 13D | Ocular Therapeutix, Inc. OCUL |
Summer Road LLC | 13,429,782 11.600% |
2,042,126 (+17.93%) |
Filing History |
| 2023-02-13 06:11 am Purchase |
2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 6,075,000 7.890% |
100,200 (+1.68%) |
Filing History |
| 2023-02-09 11:27 am Sale |
2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL |
The Vanguard Group | 3,976,853 5.160% |
-102,170 (-2.50%) |
Filing History |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BLACKROCK INC BLK |
4,952,737 6.400% |
-170,098 (-3.32%) |
Filing History |
| 2022-02-10 08:28 am Purchase |
2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
The Vanguard Group | 4,079,023 5.320% |
4,079,023 (New Position) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
BLACKROCK INC BLK |
5,122,835 6.700% |
-389,429 (-7.06%) |
Filing History |
| 2022-01-31 8:38 pm Sale |
2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 5,974,800 7.800% |
-535,200 (-8.22%) |
Filing History |